Charleen Hunt

4 Patents

• US125821042026

  Mutant Myocilin Disease Model and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US125290722026

  Transcription Modulation in Animals Using CRISPR/CAS Systems

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US118667942024

  Cas-ready Mouse Embryonic Stem Cells and Mice and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US117301502023

  Fibrillin-1 Mutations for Modeling Neonatal Progeroid Syndrome with Congenital Lipodystrophy

  Regeneron Pharmaceuticals, Inc.

  0 cites